Liver decompensation: the yard stick that measures indications and adverse effects of human albumin infusion

Bai Z, Wang L, Wang R, Zou M, Méndez-Sánchez N, Romeiro FG, et al. Use of human albumin infusion in cirrhotic patients: a systematic review and meta-analysis of randomized controlled trials. Hepatol Int [Internet]. 2022 Sep 1 [cited 31 Oct 2022]; Available from. https://doi.org/10.1007/s12072-022-10374-z

American Thoracic Society. Evidence-based colloid use in the critically ill: American Thoracic Society Consensus Statement. Am J Respir Crit Care Med. 2004;170(11):1247–1259

Article  Google Scholar 

China L, Freemantle N, Forrest E, Kallis Y, Ryder SD, Wright G, Portal AJ, Salles NB, Gilroy DW, O'Brien A, ATTIRE Trial Investigators. A randomized trial of albumin infusions in hospitalized patients with cirrhosis. N Engl J Med. 2021;384(9):808-817. https://doi.org/10.1056/NEJMoa2022166

Article  CAS  Google Scholar 

Fagan A, Gavis EA, Gallagher ML, Mousel T, Davis B, Puri P, et al. A double-blind randomized placebo-controlled trial of albumin in outpatients with hepatic encephalopathy: HEAL study. J Hepatol. 2022;S0168–8278(22):03116

Google Scholar 

Jagdish RK, Maras JS, Sarin SK. Albumin in advanced liver diseases: the good and bad of a drug! Hepatology. 2021;74(5):2848–2862

Article  CAS  Google Scholar 

Oettl K, Birner-Gruenberger R, Spindelboeck W, Stueger HP, Dorn L, Stadlbauer V, et al. Oxidative albumin damage in chronic liver failure: relation to albumin binding capacity, liver dysfunction and survival. J Hepatol. 2013;59(5):978–983

Article  CAS  Google Scholar 

留言 (0)

沒有登入
gif